Skip to content

REgistRy BRAnch goRE EndopRosthEsis

Registry on Gore Branch Endoprosthesis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06276413
Acronym
REBRA
Enrollment
50
Registered
2024-02-26
Start date
2024-03-01
Completion date
2030-12-31
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Thoracic, Aortic Dissection

Keywords

endograft

Brief summary

Multicenter registry on patients treated by the new Gore thoracic branched endoprosthesis

Detailed description

This is a multicenter, non-sponsored, physician-initiated multicenter registry on patients treated with the Gore thoracic branched endoprosthesis. Inclusion of centers is on a voluntary basis; each participating center includes consecutive patients treated with this device.

Interventions

DEVICEGORE TAG Thoracic Branch Endoprosthesis

deployment of the GORE TAG Thoracic Branch Endoprosthesis fro thoraci aorta pathologies

Sponsors

University Hospital Padova
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients receving the Gore TAG thoracic branched endograft for thoracic aorta pathologies

Exclusion criteria

* less than 18 years * allergy to endograft components * patients receiving other types of arch endografts

Design outcomes

Primary

MeasureTime frameDescription
early mortality30 daysmortality related to the intervention within 30 days
device stability5 yearsfreedom from related mortality, reintervention, type 1a endoleak during follow-up
technical success30 dayssuccesful deployment of all endograft components at the intended site with complete aneurysm exclusion, without surgical conversion, type Ia/III endoleak, kink, stenosis, graft occlusion

Secondary

MeasureTime frameDescription
early major adverse events30 daysstroke, spinal cord ischemia, vascular complications, cardiac complications, respiratory insufficiency, early reintervention, acute kidney injury

Countries

Italy

Contacts

Primary ContactMichele Antonello, PhD
michele.antonello.1@unipd.it0498212636

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026